Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients
- 1 February 1994
- journal article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 151 (2) , 261-263
- https://doi.org/10.1176/ajp.151.2.261
Abstract
Eleven panic disorder patients who panicked in response to exogenous cholecystokinin tetrapeptide (CCK-4) were rechallenged after chronic treatment with imipramine. In the rechallenge the patients displayed a marked reduction in the number and intensity of panic symptoms, duration of symptoms, frequency of panic attacks, and cardiovascular responsiveness. This study demonstrates that imipramine can antagonize the panicogenic effects of CCK-4.Keywords
This publication has 6 references indexed in Scilit:
- A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorderBiological Psychiatry, 1992
- Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findingsAmerican Journal of Psychiatry, 1992
- Enhanced Sensitivity to Cholecystokinin Tetrapeptide in Panic DisorderArchives of General Psychiatry, 1991
- Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the ratEuropean Journal of Pharmacology, 1991
- Cholecystokinin Tetrapeptide Induces Panic-like Attacks in Healthy VolunteersArchives of General Psychiatry, 1989
- Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neuronesNature, 1984